Cathepsin B: a potential prognostic marker for inflammatory breast cancer
about
Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasionInflammation and its role in age-related macular degenerationThe Regenerative Role of the Fetal and Adult Stem Cell SecretomeInflammatory breast cancer: New factors contribute to disease etiology: A reviewThe Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular MechanismsOver-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patientsCell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progressionSystemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study.Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast CancerMolecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targetsIn vivo magnetic resonance imaging of tumor protease activity.Genetics of age-related macular degeneration: application to drug designInflammatory breast cancer: high incidence of detection of mixed human cytomegalovirus genotypes associated with disease pathogenesis.Human cytomegalovirus infection enhances NF-κB/p65 signaling in inflammatory breast cancer patients.FPR1 interacts with CFH, HTRA1 and smoking in exudative age-related macular degeneration and polypoidal choroidal vasculopathy.Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration.Comparative analysis of the alveolar macrophage proteome in ALI/ARDS patients between the exudative phase and recovery phase.Inflammation and Cell Death in Age-Related Macular Degeneration: An Immunopathological and Ultrastructural Model.Genomic insights into triple-negative and HER2-positive breast cancers using isogenic model systemsDiscovery and horizontal follow-up of an autoantibody signature in human prostate cancer.Overexpression of EMMPRIN isoform 2 is associated with head and neck cancer metastasisN,N'-dinitrosopiperazine-mediated AGR2 is involved in metastasis of nasopharyngeal carcinomaMembrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancerStress-resistant Translation of Cathepsin L mRNA in Breast Cancer ProgressionAnti-inflammatory recombinant TSG-6 stabilizes the progression of focal retinal degeneration in a murine model.T-helper-associated cytokines expression by peripheral blood mononuclear cells in patients with polypoidal choroidal vasculopathy and age-related macular degenerationDifferential Impact of Cysteine Cathepsins on Genetic Mouse Models of De novo Carcinogenesis: Cathepsin B as Emerging Therapeutic Target.Quantitative electrochemical detection of cathepsin B activity in breast cancer cell lysates using carbon nanofiber nanoelectrode arrays toward identification of cancer formation.Development of a Novel Enzyme-Linked Immunosorbent Assay Targeting a Neo-Epitope Generated by Cathepsin-Mediated Turnover of Type III Collagen and Its Application in Chronic Obstructive Pulmonary Disease.Alterations in Circulating Immune Cells in Neovascular Age-Related Macular Degeneration.Semaphorin 3A attenuates cardiac autonomic disorders and reduces inducible ventricular arrhythmias in rats with experimental myocardial infarction.Expression profile of cathepsins indicates the potential of cathepsins B and D as prognostic factors in breast cancer patients.Cathepsin B inhibition limits bone metastasis in breast cancer.Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration: Complement activation in AMD.Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival.Hormonal-receptor positive breast cancer: IL-6 augments invasion and lymph node metastasis via stimulating cathepsin B expressionIdiopathic Choroidal Neovascularization: Intraocular Inflammatory Cytokines and the Effect of Intravitreal Ranibizumab Treatment.The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of diseaseCell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer.Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 years.
P2860
Q22000757-1A0526F4-7A71-43A3-A743-FE79E894E60CQ26768520-BCAE8B61-2D0D-4131-B37B-B8DD1BA1C6ACQ27004398-932DA375-4346-4DB5-B0C7-369D53E4250BQ27027856-5F5419FF-E250-4614-9BF0-0059F758E8B5Q28066752-4C8A407C-FB37-41B9-95DC-E6170EAFE973Q28273494-85CB60C6-11A9-4AD2-91E6-D57EE89EDEAEQ28299475-3637C15B-9AF7-487C-A056-F9F259551DA5Q33677692-BFF809AD-891A-4B45-9E0F-7DC436FDE991Q33760216-DBD2D558-9BB9-40A9-AB3D-E6D056874F12Q34023663-485AAEFB-B7E7-48A8-9A0D-0147673FF754Q34048774-EB517523-3BE9-4C12-BC9B-3B8BEEBEF8D6Q34103580-11215EA9-268D-4AF3-8B06-9DA8A4ACFEDDQ34163748-D138673C-2C06-4170-B605-8F3F37A8BBFAQ34589568-38E169BF-E654-49C7-A114-AD11CC9C8399Q34718497-E40745C6-76E3-4DDC-B6E6-D46130374499Q34728024-8572BC16-F908-4179-ACF0-49B9906BB426Q34774988-16154A4D-D26B-4F50-B1FA-766D1580F94AQ34875273-12DFE26B-92C9-4807-89E6-38B80EB54C37Q35005300-E9633EAC-E222-47BC-A5BD-95F4DD59D685Q35134650-180A1A2D-5696-4B14-882E-F8C378C8F2FDQ35140115-AF351F9D-A46A-45E4-B41A-B6FB1AD9916BQ35143700-1301AE64-B3B3-4CB1-B6C1-4BE5E165374EQ35586223-72717B3D-472A-4CC7-902C-B8F3E227BFA2Q35860710-029660B3-BF53-4B9E-9EA5-E1611765BC09Q35984555-9D44F426-3A42-446C-B9BD-C9A7FD2A17D4Q36041894-C21A4D19-2B53-4E62-8742-E994B5FE06CDQ36087869-50C27744-66CF-4371-9ED5-585575722C94Q36101408-0C9EB676-2966-410E-8E4F-C6CDA3784E3EQ36246370-5548C3F8-E154-4A44-A0F4-853D8E5B804CQ36287622-2D77F126-F248-415B-B300-375DBD394B48Q36480735-C2745408-DD14-46A3-A572-953448E2366EQ36502689-66FDEE94-2C73-4331-8CB7-C31FA2B6176AQ36511851-5CA587B1-69A2-4443-9167-3485BEFC9BAEQ36583714-038E4EF3-9ECE-47E7-822E-00D0FA799DA7Q37114252-1859887B-1A57-4341-9648-3F6605F1FE93Q37117208-3006DD6B-66DC-447D-B9B5-B0E4B4420A7BQ37202359-B14BBF8A-8AF8-4B62-AED2-65313439F5AFQ37215538-6D4210BA-D172-451B-BD9E-64E01C2B66EDQ37282934-BA1F1CD6-CDCC-45A5-9B10-C631446CE45FQ37498772-F3163C8F-9E87-44A5-900C-D71C09ECAA29
P2860
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
@ast
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
@en
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
@nl
type
label
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
@ast
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
@en
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
@nl
prefLabel
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
@ast
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
@en
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
@nl
P2093
P2860
P356
P1476
Cathepsin B: a potential prognostic marker for inflammatory breast cancer
@en
P2093
Bonnie F Sloane
Dora Cavallo-Medved
Hussein M Khaled
Mohamed A Shaalan
Mona M Mohamed
P2860
P2888
P356
10.1186/1479-5876-9-1
P577
2011-01-03T00:00:00Z
P5875
P6179
1002730312